In addition, cGAMP in tumor cells, acting as a secreted immunotransmitter, can enter bystander cells through connexin-mediated channels, such as the recently discovered cGAMP transporter SLC19A1, to trigger the cGAMP-STING pathway and cause IFN-β production [30]. The gene discussed is STING1; the disease is neoplasm.